North America Eyelid Surgery Blepharoplasty Market Growth Prospects 2024-2032

North America Eyelid Surgery Blepharoplasty Market Growth Prospects 2024-2032

Triton’s research analysis states that the eyelid surgery blepharoplasty market in North America is estimated to gain revenue at a CAGR of 6.79% over the forecast years 2024-2032.

The eyelid surgery blepharoplasty market in North America is experiencing notable growth, driven by rising demand for facial rejuvenation and advancements in surgical techniques. The aging population in this region significantly fuels this demand as patients seek to address drooping eyelids, excess skin, and signs of aging for a more youthful appearance. Innovations in minimally invasive techniques have also broadened the appeal of blepharoplasty as a medical treatment, attracting younger patients. Furthermore, societal emphasis on aesthetics and a growing acceptance of cosmetic procedures continue to bolster the market, particularly among women, who represent the majority of patients.

The countries researched in this region include the United States and Canada.

The United States holds the largest market share, achieving around $1762.73 million in 2023.

• The American Society of Plastic Surgeons states that of the nearly 1.5 million cosmetic surgeries performed in 2022, 115,261 were eyelid procedures in the US, highlighting the significant demand for blepharoplasty procedures.
• Eyelid procedures have experienced exponential growth in the US, with annual procedures increasing by 305% from 2000 (51,000) to over 209,000 in 2022, reflecting heightened consumer interest in cosmetic enhancements.
• Although the country lacks standardized regulations for cosmetic surgeries, allowing any licensed physician to perform eyelid surgery procedures, the popularity of nonsurgical options like laser skin tightening has influenced this market.

Eyelid Surgery Blepharoplasty Market Forecast for Canada

Canada represents a small but steadily growing market for eyelid surgeries, with procedures increasing from around 12,000 in 2016 to over 15,000 in 2022. This growth is driven by an aging population and the rising popularity of minimally invasive blepharoplasty techniques, which attract a broader range of patients. The eyelid surgery procedure is especially popular among women, who accounted for approximately 85% of surgeries in 2022, primarily motivated by the desire to address drooping eyelids and remove excess skin for a rejuvenated appearance. While the percentage of men undergoing blepharoplasty has grown slightly, it remains significantly lower than that of female patients.

The studied market is categorized into end-user, procedure type, gender, and product type. The end-user segment comprises hospital, clinics & ambulatory surgical centre. The clinics segment has seen above-average growth, driven by consumer demand for more affordable alternatives to hospital-based surgeries. Key market differentiators include personalized surgical experiences, enhanced privacy, flexible scheduling, specialized surgeon expertise, and concierge-style amenities. To boost profitability, many clinics also offer bundled packages for complementary procedures like laser skin resurfacing and brow lifts.

Contender Analysis in the Eyelid Surgery Blepharoplasty Market:

Cynosure Inc designs minimally invasive medical devices for both functional and cosmetic eyelid procedures, serving the global market. Their products target the $3 billion blepharoplasty industry. A pioneer in non-incisional laser technology for eyelid rejuvenation, the company also leads industry education efforts to promote the adoption of these innovative techniques. It is headquartered in Massachusetts, United States.

In previous years, its TempSure® Surgical platform has been honored with the Aesthetic Award for Surgical Innovation. It empowers providers to perform both surgical and nonsurgical aesthetic procedures with precision, enabling accurate incisions in delicate, thin tissues such as eyelid skin and earlobes, all using a single advanced device.

The other important contenders in the eyelid surgery blepharoplasty market are Grand Aespio Inc, Osheru LLC, Sciton Inc, Sisram Medical Ltd, Surgical Holdings, and IOPtima.